City Hall
1 Dr. Carlton B. Goodlett
Place
San Francisco, CA 94102-
4689
City and County of San Francisco
Legislation Details
File #:
Version:
1
220819
Name:
Settlement of Lawsuit - Endo Health Solutions Inc.,
Endo Pharmaceuticals Inc., Par Pharmaceutical,
Inc. and Par Pharmaceutical Companies, Inc. - City
to Receive $10,000,000 Total; $5,000,000
Immediately, $5,000,000 in 10 Equal Annual
Payments
Status:
Type:
Ordinance
Passed
File created:
In control:
7/12/2022
Clerk of the Board
On agenda:
Final action:
7/28/2022
Enactment date:
7/28/2022
170-22
Enactment #:
Title:
Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco against
Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Par Pharmaceutical, Inc. and Par
Pharmaceutical Companies, Inc. for $10,000,000 ($5,000,000 immediately and $5,000,000 paid in 10
equal annual payments); the lawsuit was filed on December 18, 2018, in the United States District
Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and
County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S.
Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly
Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler
Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva
Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals
Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC,
Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson
Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc.,
AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit
involves allegations that the Endo defendants created a public nuisance and violated the Unfair
Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and
distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of
the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid
orders as required by state and federal law.
Sponsors:
Shamann Walton, Ahsha Safai
Attachments:
1. Leg Ver1, 2. Presidential Action Memo - 30 Day Waiver 071422, 3. Board Pkt 071922, 4. Board Pkt
072622, 5. Leg Final
Action By
Date
Action
Result
Ver.
ASSIGNED
President
7/12/2022
1
PASSED ON FIRST READING
Board of Supervisors
7/19/2022
1
Pass
FINALLY PASSED
Board of Supervisors
7/26/2022
1
Pass
APPROVED
Mayor
7/28/2022
1